✦ LIBER ✦

31 Differential efficacy and toxicity profiles of 4 different schedules of gemcitabine and cisplatin combination in non-small cell lung cancer (NSCLC)

✍ Scribed by Nguyen, B.; Sandler, A.; Crino, L.; Abratt, R.P.; Steward, W.; Green, M.R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

99 Efficacy and toxicity profile of gemc

✍ Guerra, J.A.; Lianes, P.; Paz-Ares, L.; Castellano, D.; Gómez-Martín, C.; Cortés 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Efficacy and safety of gemcitabine in no

✍ Abratt, R; Bezwoda, W; Falkson, G; Goedhals, L; Hacking, D; Rugg, T 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Phase II trial assessing the combination

✍ Antón, A; Dı́az-Fernández, N; González Larriba, J.L; Vadell, C; Masutti, B; Mont 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 91 KB

P-32 Feasibility of combination of cispl

✍ Soto Parra, Hector J.; Cavina, Raffaele; Latteri, Fiorenza; Campagnoli, Elisabet 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 176 KB

159 Phase II trial of gemcitabine in com

✍ Mohedano, N.; Sanchez-Rovira, P.; Medina, B.; Flores-Gonzalez, E.; Moreno, M.A.; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Front line chemotherapy with four differ

✍ S.C. Stani; E. Bajetta; D. De Candis; P. Pozzi; E. Ferrario; D. Cortinovis; L. M 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 182 KB